au-racp MCQ (SBA): Heart failure with reduced ejection fraction and SGLT2 inhibitor use

Instant feedback + full explanation. One question, done properly.

HardCardiologyHeart failure with reduced ejection fraction and SGLT2 inhibitor useau-racpau-amc

A 68-year-old man with heart failure with reduced ejection fraction (LVEF 30%) and type 2 diabetes is stable on maximally tolerated ACE inhibitor, beta blocker and mineralocorticoid receptor antagonist. His estimated glomerular filtration rate is 65 mL/min/1.73 m2 and potassium 4.8 mmol/L. According to contemporary Australian consensus, which additional class of medicine would provide further prognostic benefit?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.

au-racp MCQ: Heart failure with reduced ejection fraction and SGLT2 in